<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><description>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 24 Mar 2021 19:31:13 +0800</pubDate><image><url>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>喜忧参半！Keytruda食管癌一线疗法获FDA批准，胃癌适应症等待清查</title><link>https://mp.weixin.qq.com/s/hXLkNtaOWAoLi2UT57rLFg</link><description></description><content:encoded><![CDATA[喜忧参半！Keytruda食管癌一线疗法获FDA批准，胃癌适应症等待清查]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>首仿！海思科「阿伐那非片」获批上市</title><link>https://mp.weixin.qq.com/s/QXiboSEGvwONkZwKXtxDYA</link><description></description><content:encoded><![CDATA[首仿！海思科「阿伐那非片」获批上市]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>首仿！东阳光「恩他卡朋片」获批上市</title><link>https://mp.weixin.qq.com/s/KVJddGCZcpNyy6MP499Lfw</link><description></description><content:encoded><![CDATA[首仿！东阳光「恩他卡朋片」获批上市]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>勃林格殷格翰精神分裂症新药获批临床</title><link>https://mp.weixin.qq.com/s/Eq_K6gKgoTX2IY7lP0BZ4g</link><description></description><content:encoded><![CDATA[勃林格殷格翰精神分裂症新药获批临床]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>甘李药业每周1次长效 GLP-1受体激动剂申报临床</title><link>https://mp.weixin.qq.com/s/8c005ISTcXPcFHVjQJRLXw</link><description></description><content:encoded><![CDATA[甘李药业每周1次长效 GLP-1受体激动剂申报临床]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>第3家！科伦药业「舒尼替尼胶囊」获批上市</title><link>https://mp.weixin.qq.com/s/fn0sH08JG-k_2JoEn1vKlA</link><description></description><content:encoded><![CDATA[第3家！科伦药业「舒尼替尼胶囊」获批上市]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:14:29 +0800</pubDate></item><item><title>长效口服紫杉醇终止开发！Odonate股价暴跌79%，公司关闭</title><link>https://mp.weixin.qq.com/s/piZpefY3AikX-D28vaXKHA</link><description></description><content:encoded><![CDATA[长效口服紫杉醇终止开发！Odonate股价暴跌79%，公司关闭]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>丽珠2020年业绩：净利润增长32%；注射用艾普拉唑钠销售17亿，增长81%，</title><link>https://mp.weixin.qq.com/s/PDnQSSyu2C-fHjIP5Cky1Q</link><description></description><content:encoded><![CDATA[丽珠2020年业绩：净利润增长32%；注射用艾普拉唑钠销售17亿，增长81%，]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>海正药业2020年业绩：扣非净利润5500万，扭亏为盈</title><link>https://mp.weixin.qq.com/s/vYURwsYuTT66FmDh3DQjVQ</link><description></description><content:encoded><![CDATA[海正药业2020年业绩：扣非净利润5500万，扭亏为盈]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>罗氏4500万美元购进的反义RNA疗法 III 期研究叫停</title><link>https://mp.weixin.qq.com/s/3c5U1Ed1t7lHpLoi9wQ1tw</link><description></description><content:encoded><![CDATA[罗氏4500万美元购进的反义RNA疗法 III 期研究叫停]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>机会！国采品种到期多省再集采，后续过评企业可竞争</title><link>https://mp.weixin.qq.com/s/O4GfSeDiCa-zJ2tZQ2orpA</link><description></description><content:encoded><![CDATA[机会！国采品种到期多省再集采，后续过评企业可竞争]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>康希诺吸入用重组新型冠状病毒疫苗获批临床</title><link>https://mp.weixin.qq.com/s/VZyjjXU9thl2e67AIuDdKQ</link><description></description><content:encoded><![CDATA[康希诺吸入用重组新型冠状病毒疫苗获批临床]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>云顶新耀复杂性腹腔内感染新药申报上市</title><link>https://mp.weixin.qq.com/s/DKkTs07skjWGAE-0HqWdZQ</link><description></description><content:encoded><![CDATA[云顶新耀复杂性腹腔内感染新药申报上市]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:09:07 +0800</pubDate></item><item><title>痛失英才！研发高管离世，阿斯利康CEO发文悼念</title><link>https://mp.weixin.qq.com/s/EEK1lv4VvO1PStzC_kKhmA</link><description></description><content:encoded><![CDATA[痛失英才！研发高管离世，阿斯利康CEO发文悼念]]></content:encoded><pubDate>Mon, 22 Mar 2021 14:50:08 +0800</pubDate></item><item><title>2款1类新药获CDE拟突破性疗法认定：来自信达、亚盛医药</title><link>https://mp.weixin.qq.com/s/tq3lXiSvL5SJ6ald9GgA9A</link><description></description><content:encoded><![CDATA[2款1类新药获CDE拟突破性疗法认定：来自信达、亚盛医药]]></content:encoded><pubDate>Mon, 22 Mar 2021 14:50:08 +0800</pubDate></item><item><title>Keytruda组合疗法通过加速批准的III期确证性研究成功</title><link>https://mp.weixin.qq.com/s/eO07gj2SODpEW4G3aKANHA</link><description></description><content:encoded><![CDATA[Keytruda组合疗法通过加速批准的III期确证性研究成功]]></content:encoded><pubDate>Mon, 22 Mar 2021 14:50:08 +0800</pubDate></item><item><title>注射剂一致性评价排行榜</title><link>https://mp.weixin.qq.com/s/zdgFYF0YW6FQa1Ypww74eg</link><description></description><content:encoded><![CDATA[注射剂一致性评价排行榜]]></content:encoded><pubDate>Sun, 21 Mar 2021 19:33:48 +0800</pubDate></item><item><title>FDA的强硬态度引发药物审查趋严担忧</title><link>https://mp.weixin.qq.com/s/SqhYxNS9Tgkc91WSp6zv4Q</link><description></description><content:encoded><![CDATA[FDA的强硬态度引发药物审查趋严担忧]]></content:encoded><pubDate>Sat, 20 Mar 2021 12:45:42 +0800</pubDate></item><item><title>基石药业精准靶向疗法「阿泊替尼片」即将获批上市</title><link>https://mp.weixin.qq.com/s/nS4rRKpl37dX7KnFASbfcA</link><description></description><content:encoded><![CDATA[基石药业精准靶向疗法「阿泊替尼片」即将获批上市]]></content:encoded><pubDate>Fri, 19 Mar 2021 16:57:10 +0800</pubDate></item><item><title>江苏：4月27日执行第四批国采中选结果</title><link>https://mp.weixin.qq.com/s/ni9gXuIIo5vkUOkk0OlDXw</link><description></description><content:encoded><![CDATA[江苏：4月27日执行第四批国采中选结果]]></content:encoded><pubDate>Fri, 19 Mar 2021 16:57:10 +0800</pubDate></item></channel></rss>